The products offered on Zengia are researched, designed and produced by Chang Gung Biotechnology, Taiwan (CGB). Their rich history includes the erection of 5 hospitals and 2 medical universities in Asia. The following are news articles regarding Chang Gung.
News abstracts regarding CGB...
References and Citations*
1 Powell, Kendall S. "California and the West; Lab-Grown Cornea Cells Transplanted; Science: Researchers Successfully Use the Cultivated Tissue to Restore Vision in 15 People with Eye Damage." The Los Angeles Times, July 13 2000.
2 Nano, Stephanie. "Study Finds Aids Drug Effective for Hepatitis B." The Advocate, October 7 2004.
3 "Chang Gung Hospital Completes Taiwan's First Split-Liver Transplants." Asia Africa Intelligence Wire, August 21 2003.
4 "Botox Eases Effects of Enlarged Prostate." Pittsburgh Post-Gazette, May 24 2006, D-2.
5 "Resistance Builds to Cipro, Study Says.". The New York Times, February 7 2002, A9, A18.
6 Chen, Sue-Hsien, Kuo-Wei Yeh, Sue-Huei Chen, Dah-Chin Yen, Teresa J. C. Yin, and Jing-Long Huang. "The Development and Establishment of a Care Map in Children with Asthma." Journal of Asthma 41, no. 8 (2004): 855-61.
7 Okie, Susan. "Tissue Grown in Lab Reverses Damage to Eye." The Washington Post, July 13 2000, A1.
8 Maggio, Paula. "Chang Gung Memorial Hospital Got Rfid System for Patient Management." M2PressWire, January 5 2007.
9 "A&M, Taiwan College Plan Exchanges." The Dallas Morning News, June 22 1989.
*Research reports, 3rd party articles and all other references noted as such are provided for informational use only and do not express the views of Zengia, LLC or Chang Gung Biotechnology.